Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

NCT01357915 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Cytomegalovirus

Interventions

PROCEDURE: Blood sampling
BIOLOGICAL: GSK149203A

Sponsor

GlaxoSmithKline